NEW YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage ...
Oasmia Pharmaceutical AB hereby issues a notification that the Company intends to repay its ...
Ready-to-use kits determine genomic characteristics of solid tumours Optimized workflow to generate results in ...
